Gene: RNF180
Official Full Name: ring finger protein 180provided by HGNC
Gene Summary: Predicted to enable ubiquitin conjugating enzyme binding activity and ubiquitin protein ligase activity. Predicted to be involved in norepinephrine metabolic process; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; and serotonin metabolic process. Predicted to act upstream of or within several processes, including adult behavior; positive regulation of protein ubiquitination; and protein polyubiquitination. Predicted to be located in endoplasmic reticulum; membrane; and nuclear envelope. Predicted to be active in endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA03246 | RNF180 Knockout cell line (AC16) | Human | RNF180 | 1:3-1:4 | negative | Online Inquiry |
| KOA18692 | RNF180 Knockout cell line (BEAS-2B) | Human | RNF180 | 1:3~1:4 | negative | Online Inquiry |
| KOA34143 | RNF180 Knockout cell line (U-2932) | Human | RNF180 | 1:2-1:4 | negative | Online Inquiry |
| KOA49548 | RNF180 Knockout cell line (TPC-1) | Human | RNF180 | 1:5-1:8 | negative | Online Inquiry |
| KOA64951 | RNF180 Knockout cell line (NCM460) | Human | RNF180 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.